electroCore, Inc. ECOR Bioelectronic Innovations — Operating Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by electroCore, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: electroCore, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about electroCore, Inc.'s bioelectronic innovations — operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is electroCore, Inc.'s bioelectronic innovations — operating income?
- electroCore, Inc. (ECOR) reported bioelectronic innovations — operating income of -$5.32M in Q1 2026.
- How has electroCore, Inc.'s bioelectronic innovations — operating income changed year-over-year?
- electroCore, Inc.'s bioelectronic innovations — operating income decreased by 39.1% year-over-year, from -$3.82M to -$5.32M.
- What does bioelectronic innovations — operating income mean?
- This is the net result of the bioelectronic innovations segment's revenue minus its cost of goods sold and operating expenses. It serves as the primary measure of the segment's operational viability and its ability to generate profit from its core business activities.